Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence
Yongmei Wang, Fanbo Jing, Haibo Wang
Advances in Therapy (2022) Vol. 39, Iss. 2, pp. 862-891
Closed Access | Times Cited: 12

Showing 12 citing articles:

Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: An extensive preclinical investigation
Md. Rizwanullah, Ahmad Perwez, Meraj Alam, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123136-123136
Closed Access | Times Cited: 15
The current landscape of aromatase inhibitors for the treatment of estrogen receptor-positive breast carcinoma
Khushboo Bhutani, S. K. Vishwakarma, Priyanka Yadav, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025) Vol. 250, pp. 106729-106729
Closed Access
Secosteroid – 1,3,4-Oxadiazole Hybrids: Synthesis and Evaluation of Their Activity Against Hormone-Dependent Breast Cancer Cells
Alexey I. Ilovaisky, Alexander M. Scherbakov, Dumitru Miciurov, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2025), pp. 106745-106745
Closed Access
Mendelian Randomization Study on Causal Association of IL-6With Breast Cancer
Min Zhang, Ning Ma, Renxi Wang
Clinical Breast Cancer (2023) Vol. 23, Iss. 4, pp. e182-e188
Closed Access | Times Cited: 4
Elacestrant in the treatment landscape of ER-positive, HER2-negative, ESR1-mutated advanced breast cancer: a contemporary narrative review
Zaheer Qureshi, Abdur Jamil, Faryal Altaf, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4624-4633
Open Access | Times Cited: 1
QbD-assisted development of lipidic nanocapsules for antiestrogenic activity of exemestane in breast cancer
Priya Singh, Alka, Priyanka Maurya, et al.
Journal of Liposome Research (2022) Vol. 33, Iss. 2, pp. 154-169
Closed Access | Times Cited: 5
Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers
Lai Wen, Jianquan Chen, Tianming Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Menopause und Sport
Sabrina Vollrath, Petra Stute
Journal für Gynäkologische Endokrinologie/Schweiz (2024) Vol. 27, Iss. 1, pp. 14-23
Open Access
Synthesis, Optimization, In Silico, and In Vitro Testing of D-Homo Lactone Estra-1,3,5-triene Derivatives
Ivana Kuzminac, Milica Z Stevanović, Dimitar Jakimov, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 3, pp. 870-881
Closed Access
A review of endocrine therapy for hormone-dependent breast cancer
А. N. Useinova, Vitalii B. Kaliberdenko, S. P. Maryanenko, et al.
Siberian Journal of Oncology (2024) Vol. 23, Iss. 3, pp. 159-167
Open Access
The Antioxidant and HDAC-Inhibitor α-Lipoic Acid Is Synergistic with Exemestane in Estrogen Receptor-Positive Breast Cancer Cells
Laura S. Pradel, Yu-Lin Ho, Holger Gohlke, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8455-8455
Open Access
Synthesis and biological evaluation of novel D-ring fused steroidal N(2)-substituted-1,2,3-triazoles
Branislava Tenjović, Sofija S. Bekić, Andjelka S. Ćelić, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Page 1

Scroll to top